Condition
Para-aortic Lymph Node Metastasis
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown1
Enrolling By Invitation1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06831032Not ApplicableRecruiting
Elective Adaptive Radiation With SBRT for Improved DurabilitY of Response
NCT06947096Enrolling By Invitation
Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients
NCT03725254Phase 2Unknown
CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC
Showing all 3 trials